Similarly in Tanzania, IMA works with the country’s Ministry of Health and Social Welfare to leverage schools and communities as NTD control platforms, and has established a corps of more than 46,000 community volunteers to provide mass drug administrations regularly. In the east African country, IMA treated more than 18 million people for at least one NTD between June 2015 and May 2016.
With support from the U.K.’s Department for International Development, IMA helps trachoma sufferers by providing them with surgical services and other case management support to help relieve pain, enable them to return to work and prevent vision loss. IMA leads implementation in Mtwara region. Since June 2015, IMA teams have performed trachomatous trichiasis surgeries for 1,358 patients and eyelid epilations for 126 patients.
With support of partners Presbyterian Church (USA) and Izumi Foundation, 480 men received hydrocele surgery since June 2015, and IMA will carry out another 140 surgeries before June 30, 2016.
Great progress has been made, and we are committed to building on these efforts. By continuing to invest in research and development, mass drug administration campaigns and efforts to raise awareness on how to prevent NTDs, we can eliminate diseases that trap over a billion people in poverty by 2020.